Search / 21 results found

from
to
  • Updated

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A judge formally approved a plan Friday, Sept. 17, 2021 to turn OxyContin maker Purdue Pharma into a new company no longer owned by members of the Sackler family and with its profits going to fight the opioid epidemic. A U.S. bankruptcy court judge signed the plan Friday, more than two weeks after giving it preliminary approval. (AP Photo/Toby Talbot, File)

  • Updated

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A federal bankruptcy judge on Wednesday, Sept. 1, 2021, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Toby Talbot, File)

  • Updated

FILE - In this Aug. 9, 2021, file photo, Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y. A federal bankruptcy judge on Wednesday, Sept. 1, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Seth Wenig, File)

  • Updated

FILE - In this Aug. 9, 2021, file photo, fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y. A federal bankruptcy judge on Wednesday, Sept. 1, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Seth Wenig, File)

  • Updated

FILE - In this Aug. 9, 2021, file photo, the outline of a protester's body with a message is seen on the sidewalk outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y. A federal bankruptcy judge on Wednesday, Sept. 1, gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades. (AP Photo/Seth Wenig, File)

  • Updated

An image of federal bankruptcy judge Robert Drain is installed by protesters in front of Purdue Pharma's headquarters, Wednesday, Sept. 1, 2021 in Stamford, Conn. The judge is preparing to rule on a plan for OxyContin maker Purdue Pharma to settle lawsuits brought by governments and others over its role in the opioid crisis. (AP Photo/Mark Lennihan)